Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1389-2029
  • E-ISSN: 1875-5488

Abstract

Heart failure (HF) is a common disease with high morbidity and mortality; however, none of the drugs available are now entirely optimal for the treatment of HF. In addition to various clinical diseases and environment influences, genetic factors also contribute to the development and progression of HF. Identifying the common variants for HF by genome-wide association studies will facilitate the understanding of pathophysiological mechanisms underlying HF. This review summarizes the recently identified common variants for HF risk and outcome and discusses their implications for the clinic therapy.

Loading

Article metrics loading...

/content/journals/cg/10.2174/1389202916999150120153141
2015-04-01
2025-10-24
Loading full text...

Full text loading...

/content/journals/cg/10.2174/1389202916999150120153141
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test